Table 2.
HIV-infected plasma samples and HIV-2 viral stocks tested by Alere Detect
| HIV status | Number of plasma samples tested |
HIV-1 M/N result* | HIV-2 result | ||
|---|---|---|---|---|---|
| Undetected | Detected | Undetected | Detected | ||
| HIV seronegative | 4 | 4 | 0 | 4 | 0 |
| HIV-1 seropositive | 22 | 5 | 17 | 22 | 0 |
| HIV-2 seropositive | 111^ | 111 | 0 | 57 | 54 |
| HIV-1 and HIV-2 dual seropositive | 8 | 5 | 3 | 5 | 3 |
| HIV-2 laboratory strain& | 4 | 4 | 0 | 0 | 4 |
*
No samples were detected for HIV-1 Group O.
^
Samples were collected from 94 participants; among them, 29 were infected by HIV-2 Group A, 2 by Group B and 1 by HIV-2 A/B recombinant virus, while the genotypes of HIV-2 infecting the rest of the participants were not determined.
&
HIV-2NIH-Z, HIV-2ROD and HIV-2EHO and HIV-2CAM-2 viral stocks.